ARCA Biopharma's IPO

ARCA Biopharma raised a round of funding on August 15, 1997. Investors include Public.

ARCA biopharma, Inc. is a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA began operations in 2005 and is headquartered in…

Articles about ARCA Biopharma's IPO: